Literature DB >> 9402781

Oxybutynin and cognitive dysfunction.

C A Donnellan1, L Fook, P McDonald, J R Playfer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402781      PMCID: PMC2127852          DOI: 10.1136/bmj.315.7119.1363

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 2.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 3.  Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

Authors:  Michael G Oefelein
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

Review 4.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 5.  Update on overactive bladder: pharmacologic approaches on the horizon.

Authors:  Eric S Rovner; Alan J Wein
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 3.092

6.  Decline in cognitive function in Parkinson's disease may be due to dementia with Lewy bodies.

Authors:  J Grace; I G McKeith
Journal:  BMJ       Date:  1998-03-28

7.  Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study.

Authors:  Simon Hill; Vik Khullar; Jean-Jacques Wyndaele; Karine Lheritier
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-06

Review 8.  Anticholinergics for Overactive Bladder in Frail and Medically Complex Older People: The Case For.

Authors:  Adrian Wagg
Journal:  Drugs Aging       Date:  2018-09       Impact factor: 3.923

Review 9.  Intravesical oxybutynin in the pediatric neurogenic bladder.

Authors:  John Lazarus
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

10.  Tolterodine extended release is well tolerated in older subjects.

Authors:  T L Griebling; S R Kraus; H E Richter; D B Glasser; M Carlsson
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.